vTv Therapeutics competes with numerous pharmaceutical and biotechnology enterprises specializing in metabolic research, immunology, and diabetes care. Competitors range from massive global drug manufacturers developing advanced insulin delivery systems and oral hypoglycemic agents to specialized clinical-stage biotech firms focused on innovative small-molecule therapies and immune-modulating treatments.